1
Hagendijk, Marije E, van der Schans, Simon, Boersma, Cornelis, Postma, Maarten J, van der Pol, Simon
Veröffentlicht in: Hagendijk , M E , van der Schans , S , Boersma , C , Postma , M J & van der Pol , S 2021 , ' Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 6 , pp. 991-999 . https://doi.org/10.1007/s10198-021-01303-2;
2021
Veröffentlicht in: Hagendijk , M E , van der Schans , S , Boersma , C , Postma , M J & van der Pol , S 2021 , ' Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands ' , European Journal of Health Economics , vol. 22 , no. 6 , pp. 991-999 . https://doi.org/10.1007/s10198-021-01303-2;
2021
2
Velikanova, Rimma, van der Schans, Simon, Bischof, Matthias, van Olden, Rudolf Walther, Postma, Maarten, Boersma, Cornelis
Veröffentlicht in: Velikanova , R , van der Schans , S , Bischof , M , van Olden , R W , Postma , M & Boersma , C 2022 , ' Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands ' , Value in Health , vol. 25 , no. 10 , pp. 1696-1704 . https://doi.org/10.1016/j.jval.2022.06.010;
2022
Veröffentlicht in: Velikanova , R , van der Schans , S , Bischof , M , van Olden , R W , Postma , M & Boersma , C 2022 , ' Cost-Effectiveness of Newborn Screening for Spinal Muscular Atrophy in The Netherlands ' , Value in Health , vol. 25 , no. 10 , pp. 1696-1704 . https://doi.org/10.1016/j.jval.2022.06.010;
2022
3
van der Schans, Simon, Vondeling, Gert T, Cao, Qi, van der Pol, Simon, Visser, Sipke, Postma, Maarten J, Rozenbaum, Mark H
Veröffentlicht in: van der Schans , S , Vondeling , G T , Cao , Q , van der Pol , S , Visser , S , Postma , M J & Rozenbaum , M H 2020 , ' The impact of patent expiry on drug prices : insights from the Dutch market ' , Journal of market access & health policy , vol. 9 , no. 1 , 1849984 . https://doi.org/10.1080/20016689.2020.1849984;
2020
Veröffentlicht in: van der Schans , S , Vondeling , G T , Cao , Q , van der Pol , S , Visser , S , Postma , M J & Rozenbaum , M H 2020 , ' The impact of patent expiry on drug prices : insights from the Dutch market ' , Journal of market access & health policy , vol. 9 , no. 1 , 1849984 . https://doi.org/10.1080/20016689.2020.1849984;
2020